Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate
Authors:
Open Access
- 1 July 2007
- journal article
- case report
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 9 (3) , 373-377
Abstract
Methotrexate (MTX) is a widely used chemotherapeutic agent that can cause acute, subacute, and chronic neurological complications. Subacute MTX neuroKeywords
This publication has 25 references indexed in Scilit:
- Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging featuresPediatric Radiology, 2005
- Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children2005
- Diffusion-Weighted MRI Correlates of Subacute Methotrexate-Related NeurotoxicityJournal of Neuro-Oncology, 2005
- Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRIJournal of Neuro-Oncology, 2005
- Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome2004
- Diffusion-weighted MRIs in an acute leukoencephalopathy following intrathecal chemotherapyNeurology, 2004
- White Matter and Cerebral Metabolite Changes in Children Undergoing Treatment for Acute Lymphoblastic Leukemia: Longitudinal Study with MR Imaging and1H MR SpectroscopyRadiology, 2003
- Transient encephalopathy following high-dose methotrexateMedical and Pediatric Oncology, 2003
- MR findings in methotrexate-induced CNS abnormalitiesAmerican Journal of Roentgenology, 1989
- Transient cerebral dysfunction following chemotherapy for osteogenic sarcomaAnnals of Neurology, 1978